Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5116 AL 5130

Configuration-specific immunotherapy targeting cis pThr231-Pro232 tau for Alzheimer disease

Wang JZ, Zhang Y.

J Neurol Sci. 2015 Jan 15;348(1-2):253-5. doi: 10.1016/j.jns.2014.11.011. Epub 2014 Nov 13.

Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?

Loeffler DA.

J Neuroinflammation. 2014 Dec 5;11:198. doi: 10.1186/s12974-014-0198-z.

Phytomedicines as potential inhibitors of β amyloid aggregation: significance to Alzheimer's disease

Kumar NS, Nisha N.

Chin J Nat Med. 2014 Nov;12(11):801-18. doi: 10.1016/S1875-5364(14)60122-9.

Pharmacotherapy of Alzheimer's disease: current and future trends

Geldenhuys WJ, Darvesh AS.

Expert Rev Neurother. 2015 Jan;15(1):3-5. doi: 10.1586/14737175.2015.990884. Epub 2014 Dec 8.

Alzheimer disease immunotherapeutics: then and now

Jindal H, Bhatt B, Sk S, Singh Malik J.

Hum Vaccin Immunother. 2014;10(9):2741-3. doi: 10.4161/21645515.2014.970959. Epub 2014 Oct 31.

Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets

Prakash A, Kalra J, Mani V, Ramasamy K, Majeed AB.

Expert Rev Neurother. 2015 Jan;15(1):53-71. doi: 10.1586/14737175.2015.988709. Epub 2014 Dec 12.

Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication

Deardorff WJ, Shobassy A, Grossberg GT.

Expert Rev Neurother. 2015 Jan;15(1):7-17. doi: 10.1586/14737175.2015.995639. Epub 2014 Dec 15.

Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies

Kamat PK, Kalani A, Rai S, Swarnkar S, Tota S, Nath C, Tyagi N.

Mol Neurobiol. 2016 Jan;53(1):648-661. doi: 10.1007/s12035-014-9053-6. Epub 2014 Dec 17.

Severe hyponatremia due to escitalopram treatment in an elderly adult with Alzheimer's disease

Soysal P, Isik AT.

J Am Geriatr Soc. 2014 Dec;62(12):2462-3. doi: 10.1111/jgs.13149.

Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer's patients in long-term care health facilities

Meguro K, Ouchi Y, Akanuma K, Meguro M, Kasai M.

BMC Neurol. 2014 Dec 17;14:243. doi: 10.1186/s12883-014-0243-7.

Resveratrol as a therapeutic agent for Alzheimer's disease

Ma T, Tan MS, Yu JT, Tan L.

Biomed Res Int. 2014;2014:350516. doi: 10.1155/2014/350516. Epub 2014 Nov 26.

Collaborative transdisciplinary team approach for dementia care

Galvin JE, Valois L, Zweig Y.

Neurodegener Dis Manag. 2014;4(6):455-69. doi: 10.2217/nmt.14.47.

Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future

Hampel H, Schneider LS, Giacobini E, Kivipelto M, Sindi S, Dubois B, Broich K, Nisticò R, Aisen PS, Lista S.

Expert Rev Neurother. 2015 Jan;15(1):83-105. doi: 10.1586/14737175.2015.995637. Epub 2014 Dec 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias